We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALBO
2701
DELISTED
Albireo Pharma Inc
ALBO
$55K ﹤0.01%
2,367
-1,454
-38% -$38.7K
HAAC
2702
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
$55K ﹤0.01%
5,638
+2,944
+109% +$28.9K
ANIK icon
2703
Anika Therapeutics
ANIK
$288M
$54K ﹤0.01%
1,507
+320
+27% +$12.8K
CCO icon
2704
Clear Channel Outdoor Holdings
CCO
$1.19B
$54K ﹤0.01%
16,143
-15,962
-50% -$49.7K
CCS icon
2705
Century Communities
CCS
$2.01B
$54K ﹤0.01%
659
-19,534
-97% -$1.4M
CRNT icon
2706
Ceragon Networks
CRNT
$200M
$54K ﹤0.01%
20,819
+2,098
+11% +$6.32K
CSR
2707
Centerspace
CSR
$938M
$54K ﹤0.01%
491
-489
-50% -$50.5K
GDOT icon
2708
Green Dot
GDOT
$771M
$54K ﹤0.01%
1,476
-4,290
-74% -$175K
HUBG icon
2709
HUB Group
HUBG
$2.46B
$54K ﹤0.01%
1,268
-3,638
-74% -$145K
KRON
2710
DELISTED
Kronos Bio
KRON
$54K ﹤0.01%
3,985
+3,017
+312% +$47.2K
MREO
2711
Mereo BioPharma
MREO
$50.9M
$54K ﹤0.01%
33,681
+33,052
+5,255% +$66.1K
NICE icon
2712
Nice
NICE
$5.99B
$54K ﹤0.01%
178
-2,417
-93% -$698K
BNIX
2713
DELISTED
Bannix Acquisition Corp. Common Stock
BNIX
$54K ﹤0.01%
+5,485
New +$53.9K
FXLV
2714
DELISTED
F45 Training Holdings Inc.
FXLV
$54K ﹤0.01%
4,922
+4,173
+557% +$52.2K
VLTA
2715
DELISTED
Volta Inc.
VLTA
$54K ﹤0.01%
+7,430
New +$65.3K
FSTX
2716
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$54K ﹤0.01%
10,745
+10,574
+6,184% +$63.8K
ASUR icon
2717
Asure Software
ASUR
$245M
$53K ﹤0.01%
6,882
+6,814
+10,021% +$59.6K
EDU icon
2718
New Oriental
EDU
$8.36B
$53K ﹤0.01%
2,522
+105
+4% +$2.27K
GNE icon
2719
Genie Energy
GNE
$383M
$53K ﹤0.01%
+9,543
New +$52.7K
IHRT icon
2720
iHeartMedia
IHRT
$457M
$53K ﹤0.01%
2,521
-3,920
-61% -$83K
RACE icon
2721
Ferrari
RACE
$72.9B
$53K ﹤0.01%
204
-4,066
-95% -$1M
ORTX
2722
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$53K ﹤0.01%
3,961
+2,223
+128% +$36.8K
AVCT
2723
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$53K ﹤0.01%
+1,456
New +$43.9K
ENIA
2724
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$53K ﹤0.01%
9,736
+2,387
+32% +$14.2K
AUDC icon
2725
AudioCodes
AUDC
$255M
$52K ﹤0.01%
+1,511
New +$52.7K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.